http://articles.mercola.com/sites/articles/archive/2000/04/16/new-celebrex-clone.aspxThe US Food and Drug Administration April 13 approved a new painkiller, Mobic, to treat osteoarthritis. Mobic, or meloxicam, will be marketed by Boehringer Ingelheim and Chicago-based Abbott Laboratories. The new drug would compete against GD Searle'senCommunityServer 2008.5 SP1 (Build: 31106.3070)